Hongchang International Company Ltd (HCIL)

[splintered sunlight]

Way to go!!!!!

[JJZander]

Sweet

[Ringrock]

Got out most @.095…

[amelow]

Bid moving up nicely
Interesting…

[splintered sunlight]

Agreed

[amelow]

Like seeing the volume starting to pick up as share price increases ??

[splintered sunlight]

Much bigger moves

[amelow]

IF i could sell my shares for the 0.09 I'd almost have a triple
I dont think i can if I tried to sell them as volume isn't enough to swallow them.
very thin, so let's hope we much bigger moves soon.
Cheers

[Mike2019]

Np, at this point I just want part of my investment back since my average is way too high. I'm happy that this thing is still alive! Cheers!

[amelow]

Thanks Mike!
Anything sounds great, and the fact they are still alive is immediate value.
Let's make some money!
Cheers

[Mike2019]

Long time holder here too since PWEB. Went through their latest filings and I think why the price is moving is because of their latest appointment of an independant director. Also, they stated that they were looking for a possible merger/acquisition moving forward. The market is probably anticipating an announcement soon.

[amelow]

Nope, wish I knew but hopefully something good!
I bought as PWEB too and went through the reverse split etc.
Had some movement on other quiet pennies over the last year so let's hope that is in the works here.
Good luck!

[buffalo fan]

Long time holder since was PWEB. Saw recent price upward movement. Does anyone know what may be in the works on this one?

TIA

[amelow]

Been here since 2018 and through one reverse split.
Wrote it off like many of my BBs but have had two come to life over the last year. Hopefully we are waking up.
Cheers

[splintered sunlight]

Actually not a long time holder - recent.

You?

Yes we need at least a couple hundred more peeps.

Cheers

[amelow]

Yes! we just need a couple hundred more peeps.
Longtime holder?
Cheers

[splintered sunlight]

I'm here.

[amelow]

.09 and still nobody here.
asking .12
Can't wait until the boards are busy to see what the pricing will be then...

[amelow]

Trades going in the .07s now on bigger volume
ask moved up to .12
and nobody here....

[amelow]

We are getting some volume and B/A increased
Let's (finally) make some money here!

[splintered sunlight]

They raised it - it used to be 12 shares lol.......

[amelow]

14 shares again and again ?!
0.84 per trade, WTF is the significance

[JJZander]

.05

[splintered sunlight]

Not so insanely.....

[Garyst]

True. 100k bidding.012 up now

[JJZander]

And thin downward lol

[Garyst]

This thing is insanely thin to .45 HYBT

[JJZander]

Back to 03

[zino]

Bio-techs hot lately...Gltu

[zino]

Biotechs Hot... Could reverse the process of Cancer
by converting selenium into nickel inside cells (Pg. 16)
https://www.otcmarkets.com/filing/html?id=16391322&guid=Nd7-kaxCCotsdth

[zino]

Quantized Space Therapy Chamber to treat Cancer through cold nuclear fusion
https://www.otcmarkets.com/filing/html?id=16391322&guid=Nd7-kaxCCotsdth

[dangerousrhythm]

Went pink today

[GoingBig35]

Been holding since PWEB too. Interesting things seem to be happening.

[DFLY]

Yup ha. Nice 300 share paint to bid interesting hmmm lol

the games already starting...GL for anyone getting ANY size in subs lol

[toytundra]

I've been holding this since I had a scottrade account. I think the ticker was PWEB.

[Golden Cross]

Good deal

[DFLY]

Wow 028 last .24s up...float back to NADA!

[DFLY]

Hys back buddy!!

To prepare for the mass production of Chambers, Kangzi is conducting clinical experiments to make further improvements on Chamber and adjusting features of the mass-production mold for Chamber. Kangzi is also in the process of obtaining official governmental permits from relevant government authorities to produce and sell Chambers on a national scale. As its long-term business strategy, Kangzi focuses on researching, developing, and manufacturing high-technology medical equipment while targeting both individual and institutional customers. It plans to massively manufacture Chambers in small and medium sizes, establish operation centers to sell Chambers in various cities across China, and initiate advertising and marketing campaigns on different media platforms. Kangzi will also monetize on services provided to customers who use Chambers and other medical products.

In addition to business activities related to Chamber, the Company will commit to the research, development, manufacturing, and sale of healthcare equipment and various health products containing natural plants, including cosmetics, nutritional supplements, and drugs. In the near future, the Company aims to standardize and internationalize the production and sale of healthcare equipment and health products, while increasing its brand awareness in the healthcare and consumer-product markets.

[DFLY]

Lets do thisss! Coming back from DOA status..man how thin still peanut float

and even some revs now.

Pursuant to the terms of the Share Transfer Agreement entered into by JSEL and Kangzi on January 17, 2019, JSEL has the right to monitor and manage all aspects of operation of Kangzi, including its research and development activities relating to the Chamber. As the development of the Chamber enters its final stage at Kangzi, JSEL started accepting pre-orders for the Chamber in September. Subsequently, on October 15 2019, JSEL entered into a clinical cooperation agreement (the “Clinical Cooperation Agreement”) with Shenzhen Saikun Biotechnology Co., Ltd. (“Saikun”). Pursuant to the Clinical Cooperation Agreement, Saikun agreed to pay JSEL 5.5 million RMB as the total preordering payment. 1.5 million RMB and 1.5 million RMB were delivered to JSEL respectively on September 7 and September 27, 2019. The parties are working on the timing for payment of the remaining 2.5 million RMB due under the Clinical Cooperation Agreement. In exchange, JSEL is obligated to purchase all the components of a Chamber from Kangzi, fully assemble it, and conduct a clinical trial with Saikun, third-party hospital partners, and patients using the Chamber. Specifically, after receiving the full amount of payment from Saikun, JSEL shall transport the Chamber to its preferred location, properly install it, and conduct a clinical trial that lasts at least one month. During the clinical trial, JSEL shall provide training sessions regarding the proper operation of the Chamber to Saikun’s employees. Both Saikun and JSEL are obligated to find third-party hospitals whom will agree to act as partners to co-host the clinical trial and patients whom will be voluntarily willing to undergo treatment provided by the Chamber. While Saikun is responsible for various expenses related to the clinical trial, JSEL is responsible for communicating with patients receiving treatment and other patient-related administrative matters. When JSEL determines that Saikun is capable of properly operating the Chamber and managing activities related to the Chamber, Saikun may request JSEL to move the Chamber to a location designated by Saikun and reinstall it. Furthermore, upon the successful completion of the clinical trial, JSEL shall provide Saikun governmental permits necessary for the operation of the Chamber, and Saikun shall operate the Chamber and provide related services to patients under the supervision of JSEL. In addition, JSEL shall transfer the right of using the Chamber and any beneficiary right affiliated to using the Chamber to Saikun upon receiving the full amount of payment from Saikun. JSEL, nevertheless, owns all the intellectual property rights affiliated with the Chamber. If the two parties decide to terminate the Clinical Cooperation Agreement prior to the expiration of the term, Saikun’s right of using the Chamber during the term is still effective as long as its use of the Chamber does not infringe any of JSEL’s intellectual property rights affiliated with the Chamber. The two parties agreed that the term of the Clinical Cooperation Agreement would not end until Kangzi successfully obtains permits issued by relevant government entities supervising development and sale of medical equipment.



To prepare for the mass production of Chambers, Kangzi is conducting clinical experiments to make further improvements on Chamber and adjusting features of the mass-production mold for Chamber. Kangzi is also in the process of obtaining official governmental permits from relevant government authorities to produce and sell Chambers on a national scale. As its long-term business strategy, Kangzi focuses on researching, developing, and manufacturing high-technology medical equipment while targeting both individual and institutional customers. It plans to massively manufacture Chambers in small and medium sizes, establish operation centers to sell Chambers in various cities across China, and initiate advertising and marketing campaigns on different media platforms. Kangzi will also monetize on services provided to customers who use Chambers and other medical products.



In addition to business activities related to Chamber, the Company will commit to the research, development, manufacturing, and sale of healthcare equipment and various health products containing natural plants, including cosmetics, nutritional supplements, and drugs. In the near future, the Company aims to standardize and internationalize the production and sale of healthcare equipment and health products, while increasing its brand awareness in the healthcare and consumer-product markets.

[amelow]

Gone but not forgotten come on baby! Saddle up boys this could be fun…

[DFLY]

Lets goOO! Rising up from the ashes baby!

[toytundra]

WOOOOO HOOOOO

[DFLY]

We back!!!!!!

[DFLY]

HYBT BACK!!! PS CURRENT!!!!!

[DFLY]

Another 8k out. Expediting filings etc! Maybe HY can get back trading yet!

Bring it!

[DFLY]

Well 8k out hired new CFO tied to 2 Nas plays.

I'm happy to see it as it seems like they going to try and get things right here with OTC. Why else hire a new CFO at this point? So there is HOPE and potential light at end the HYBT tunnel! Will see!

[Golden Cross]

Thanks for the update... $HYBT

[dealerschool2006]

HYBT Stop sign back now...company seams to have higher lows through out the year...

[GoingBig35]

Hey Now... Let's go!

[Golden Cross]

HYBT Stop sign gone now